WEBULL
WebtradeDownload

Can HCA Healthcare (HCA) Trade At A Discount As Cash Flow Holds?

Simply Wall St · 2d ago

HCA Healthcare has delivered a strong share price journey in recent years, which puts fresh focus on what investors are really paying for in terms of its cash flows. With new headlines ranging from legal questions around tracking cookies to portfolio reshaping through asset sales, the issue now is whether today's valuation lines up with the cash the business can generate over time.

  • Over the past 3 years HCA Healthcare has returned 93.2%, which raises the stakes on whether the cash flowing out of the hospitals can support this kind of share price outcome.
  • Recent developments, including the sale of 31 home health and hospice locations and a contract dispute with a major insurer, may shift how investors think about future cash flow stability, reimbursement terms and where capital gets directed inside the group.
  • Prefer to judge HCA Healthcare on earnings? See what HCA Healthcare's 14.6x P/E says about the price.

For investors, the debate is whether HCA Healthcare's current share price is adequately grounded in the cash flows implied by a Discounted Cash Flow (DCF) view of the business.

If you want a comparison point for HCA Healthcare's cash flow story, it helps to line it up against other businesses on a similar value lens using 32 high quality undervalued stocks.

Is HCA Healthcare a Bargain on Cash Flow?

The Discounted Cash Flow (DCF) model here is built around the cash HCA Healthcare is expected to return to shareholders over time. Latest twelve month free cash flow comes in at about $6.0b, and the projections used in the model assume that this figure grows over the next decade rather than shrinking, with later years tapering to a steadier pace that fits a large, established hospital operator.

On that cash profile, the DCF output suggests an estimated intrinsic worth that sits substantially above the current share price of $460.75. The class-action lawsuit over tracking cookies, and the questions it raises around privacy practices, helps explain why the market is cautious even if the cash flow path in the model remains relatively stable. Investors who want to see how that gap looks in more detail can drill into the full set of assumptions and outputs in. Find out what HCA Healthcare could be worth using our Discounted Cash Flow (DCF) estimate.

The HCA Healthcare Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where that valuation gap for HCA Healthcare leaves you by spelling out which paths for growth, profitability and earnings would need to hold for the stock to be worth materially more or less than where it trades today on the market. Each narrative moves beyond a single multiple or model output and lays out the assumptions that sit under its idea of fair value so you can compare those expectations with actual results as they are reported.

The community is split on HCA Healthcare, with one camp seeing more upside in its scale and cash generation while the other thinks much of that strength is already reflected.

Bull case: 27% undervalued

"HCA’s footprint is enormous. With hospitals, surgery centers, and outpatient facilities spread across the U.S., the company benefits from scale..."

Discover why this Narrative puts HCA Healthcare at 27% undervalued.

Bear case: roughly fairly valued

"The main thing that has to go right is that HCA Healthcare continues to offset payer mix and coverage headwinds, including health insurance exchange and Medicaid shifts, with its cost program..."

Explore why this Narrative puts HCA Healthcare at roughly fairly valued.

For HCA Healthcare, the people in charge matter as much as the price

Cash flow models only tell part of the story, because the real course for HCA Healthcare is set by the executives in the cockpit and the way their pay packets are structured. See who runs HCA Healthcare and how they are paid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.